Literature DB >> 1233228

Mechanism of the inhibitory effect of PAS granules on the absorption of rifampicin: adsorption of rifampicin by an excipient, bentonite.

G Boman, P Lundgren, G Stjernström.   

Abstract

The bioavailability (plasma concentrations, AUC and urinary excretion) of an oral solution of rifampicin was investigated in six healthy volunteers. Simultaneous administration of PAS granules produced a significant decrease in the absorption of RMP, whereas Na-PAS tablets had no effect. This indicated that the dosage form of the granules and not PAS itself was responsible for the interaction, and that the dissolution of RMP was not involved. The interaction could be reproduced by giving dummy granules that contained the same excipients but no PAS. The disintegration and dissolution of PAS granules in vitro correlated well with the disappearance of RMP from the solution. The major excipient of the granules, bentonite (a mineral closely related to kaolin), was found to adsorb rifampicin rapidly and strongly.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233228     DOI: 10.1007/bf00562653

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  IN VITRO ADSORPTION OF SOME ANTICHOLINERGIC DRUGS BY VARIOUS ANTACIDS.

Authors:  S M BLAUG; M R GROSS
Journal:  J Pharm Sci       Date:  1965-02       Impact factor: 3.534

2.  Some physicochemical properties of the montmorillonites.

Authors:  K N Wai; G S Banker
Journal:  J Pharm Sci       Date:  1966-11       Impact factor: 3.534

3.  Binding of rifampicin by human plasma proteins.

Authors:  G Boman; V A Ringberger
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

4.  Drug interaction: decreased serum concentrations of rifampicin when given with P.A.S.

Authors:  G Boman; A Hanngren; A Malmborg; O Borgå; F Sjöqvist
Journal:  Lancet       Date:  1971-04-17       Impact factor: 79.321

5.  Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid.

Authors:  G Boman
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

6.  Metabolic study and controlled clinical trials of rifampin.

Authors:  S Sunahara; H Nakagawa
Journal:  Chest       Date:  1972-06       Impact factor: 9.410

7.  Effect of adsorbents on drug absorption. I. Modification of promazine absorption by activated attapulgite and activated charcoal.

Authors:  D L Sorby
Journal:  J Pharm Sci       Date:  1965-05       Impact factor: 3.534

8.  Rifampicin in plasma and pleural fluid after single oral doses.

Authors:  G Boman; A S Malmborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

9.  Adsorption of phenothiazine derivatives by solid adsorbents.

Authors:  D L Sorby; E M Plein; J D Benmaman
Journal:  J Pharm Sci       Date:  1966-08       Impact factor: 3.534

  9 in total
  10 in total

Review 1.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Serum concentrations and bioavailability of rifampicin and isoniazid in combination.

Authors:  J C Garnham; T Taylor; P Turner; L F Chasseaud
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

Review 3.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

Review 4.  Adverse antibiotic drug interactions.

Authors:  A J Bint; I Burtt
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

Review 5.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 6.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Pharmacokinetic interactions with rifampicin.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 8.  Pharmacokinetic drug interactions with antimicrobial agents.

Authors:  J G Gillum; D S Israel; R E Polk
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

9.  Can small drugs predict the intrinsic aqueous solubility of 'beyond Rule of 5' big drugs?

Authors:  Alex Avdeef; Manfred Kansy
Journal:  ADMET DMPK       Date:  2020-04-25

10.  Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations.

Authors:  Lyndsey L Anderson; Maia G Etchart; Dilara Bahceci; Taliesin A Golembiewski; Jonathon C Arnold
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.